聚桂醇注射液与无水乙醇超声引导下治疗肝血管瘤疗效比较

发布时间：2018-03-03 01:12

本文选题：聚桂醇注射液　切入点：无水乙醇　出处：《介入放射学杂志》2017年10期 　论文类型：期刊论文

【摘要】：目的探讨聚桂醇注射液与无水乙醇超声引导下经皮穿刺治疗肝血管瘤的临床疗效与安全性。方法 60例肝血管瘤患者随机分为无水乙醇组和聚桂醇组,每组30例,对比两组患者临床疗效及不良反应发生率。结果每组临床疗效对比差异无统计学意义(P=0.489,P0.05),无水乙醇组不良反应发生率明显高于聚桂醇组,差异有统计学意义(χ2=5.963,P=0.03,P0.05)。结论超声引导下经皮穿刺聚桂醇注射液与无水乙醇治疗肝血管瘤临床疗效相当,但聚桂醇组不良反应少,疼痛率低,患者耐受性好,此治疗方法值得临床推广应用。
[Abstract]:Objective to investigate Lauromacrogol Injection and ethanol under ultrasound guided by clinical efficacy and safety of percutaneous treatment of hepatic hemangioma. Methods 60 cases of patients with hepatic hemangioma were randomly divided into ethanol group and lauromacrogol group, 30 cases in each group, and adverse reaction were compared between two groups of clinical incidence. Results there was no significant difference comparison of clinical efficacy of each group (P=0.489, P0.05), occurrence rate of adverse reactions of ethanol group was significantly higher than that of lauromacrogol group, the difference was statistically significant (2=5.963, P=0.03, P0.05). Conclusion ultrasound guided percutaneous ethanol and Lauromacrogol Injection for treatment of liver hemangioma clinical efficacy, but lauromacrogol group has less adverse reactions pain, low rate, with good tolerance, this treatment is worthy of clinical application.

【作者单位】：新疆石河子大学医学院第一附属医院消化内科;
【分类号】：R445.1;R735.7

【相似文献】